Translate to...

European Union executive signs remdesivir deal with Gilead

European Union executive signs remdesivir deal with Gilead
Spinant said the contract was worth 63 million euros ($73.99 million) and would provide treatment to 30,000 patients with severe COVID-19 symptoms.